Wednesday, March 25, 2020
Use and Potential Adverse Effects of Chloroquine & Hydroxychloroquine for COVID-19
Several medications are being evaluated in studies or are being used off-label to treat COVID-19 infections. In response to several recent poisonings and one death associated with the use of chloroquine to treat COVID-19, the American College of Medical Toxicology (ACMT) is offering this free webinar Medical & Public Health Considerations of Chloroquine & Hydroxychloroquine Use during the COVID-19 Pandemic on Wednesday March 25, 2020 at 3pm EDT. Join this briefing to learn from leading medical toxicologists, experts in the care of poisoned patients, as they discuss the use of, and potential adverse effects with, these drugs as physicians consider these therapies to treat patients with COVID-19.
Medical Toxicology experts from ACMT will partner with medical toxicologists from the European Association of Poison Control Centres and Clinical Toxicologists (EAPCCT) and the Middle East and North Africa Clinical Toxicology Association (MENATOX) to discuss the current use of these drugs for COVID-19 in France as well as the potential adverse effects when used for therapeutic purposes, in excessive doses, and in overdose.
Series Partners
American Academy of Clinical Toxicology (AACT) | American Academy of Emergency Medicine (AAEM) | American Association of Poison Control Centers (AAPCC) | American College of Medical Toxicology (ACMT) | Asia Pacific Association of Medical Toxicologists (APAMT) | European Association of Poison Centers and Clinical Toxicologists (EAPCCT) | Middle East & North Africa Clinical Toxicology Association (MENATOX)
Moderators:
 |
 |
| Dr. Paul Wax ACMT Executive Director |
Dr. Ziad Kazzi |
 |
 |
| Dr. Michelle Ruha ACMT President |
Dr. Bruno Megarbane EAPCCT Past President Professor, Dept. of Medical & Toxicological Critical Care Lariboisière Hospital, Paris, France |